Impaired microvascular endothelial function in vitamin D-deficient diabetic nephropathy patients

Journal of Cardiovascular Medicine

Volumn 14, Issue 6, 2013, Pages 466-471

  Munisamy, S ^a   Kamaliah, M D ^a   Suhaidarwani, A H ^a   Zahiruddin, W M ^a   Rasool, A H ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Diabetic nephropathy; High sensitivity C reactive protein; Microvascular endothelial function; Vitamin D status

Indexed keywords

25 HYDROXYVITAMIN D; ACETYLCHOLINE; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IONTOPHORESIS; MALE; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MICROVESSELS; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN; VASODILATION; VASODILATOR AGENTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84879499857     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283590d3d     Document Type: Article

References (51)

1. Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study. Kidney Int 2003; 63:1499-1507. (Pubitemid 36350016)
2. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17:986-993. (Pubitemid 39361674)
3. van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc 2010; 17:3-8.
4. Foley RN, Culleton BF, Parfrey PS, et al. Cardiac disease in diabetic end-stage renal disease. Diabetologia 1997; 40:1307-1312. (Pubitemid 27469671)
5. Scragg R, Sowers M, Bell C. Serum 25-Hydroxyvitamin D, diabetes, and ethnicity in the third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27:2813-2818. (Pubitemid 39565042)
6. Martin T, Keith R. Vitamin D and diabetes. Diabetes Spectrum 2011; 24:113-118.
7. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92:39-48. (Pubitemid 43831966)
8. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94:483-492. (Pubitemid 41555486)
9. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49:1063- 1069. (Pubitemid 351664326)
10. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168:1174-1180. (Pubitemid 351831400)
11. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke 2006; 37:243-245. (Pubitemid 43732081)
12. Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease results fromNHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008; 28:1179-1185.
13. Kilkkinen A, Knekt P, Aro A, et al. Vitamin D Status and the risk of cardiovascular disease death. Am J Epidemiol 2009; 170:1032-1039.
14. Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease. Hypertension 2008; 52:249-255.
15. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. J Am Coll Cardiol 2003; 92:17-22.
16. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107:363-436.
17. Balakumar P, Chakkarwar VA, Krishan P, Singh M. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? Biomed Pharmacother 2009; 63:171-179.
18. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. Arterioscler Thromb Vasc Biol 2003; 23:168-175.
19. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42:1149-1160. (Pubitemid 37188333)
20. Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34:55-68. (Pubitemid 27261913)
21. Stehouwer CD. Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for nondiabetic renal disease. Nephrol Dial Transplant 2004; 19:778-781. (Pubitemid 38455645)
22. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes 2002; 51:1157- 1165.
23. Stehouwer CD, Zeldenrust GC, den Ottolander GJ, et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in noninsulin-dependent diabetes mellitus. Lancet 1992; 340:319- 323.
24. Stehouwer CD, Fischer HR, van Kuijk AW, Polak BC, Donker AJ. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 1995; 44:561-564.
25. Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 2008; 18:109-116. (Pubitemid 351802262)
26. Brodsky SV, Gealekman O, Chen J, et al. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesityinduced diabetes by Ebselen. Circ Res 2004; 94:377-384. (Pubitemid 38240730)
27. Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95:4584-4591.
28. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89:552-572. (Pubitemid 36592083)
29. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357:266-281.
30. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008; 88:500-506.
31. Fadem SZ, Rosenthal B. MDRD Calculator (2000-2011). Nephron Information Center. Available online at http://www.kidney.org/ professional/kdoqi/gfr- calculator.cfm (accessed 19 July 2010).
32. Al-Tahami BA, Yvonne-Tee GB, Halim AS, Ismail AA, Rasool AHG. Impaired microvascular endothelial function in relatively young obese humans is associated with altered metabolic and inflammatory markers. Clin Hemorheol Microcirc 2011; 47:87-97.
33. de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance Circulation 2004; 109:2529-2535. (Pubitemid 38720552)
34. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with Type 2 diabetes. J Clin Endocrinol Metab 2011; 96:E830-E835.
35. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999- 1007. (Pubitemid 41262334)
36. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011; 57:63-69.
37. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25:320-325. (Pubitemid 351322698)
38. Harris RA, Pedersen-White J, Guo DH, et al. Vitamin D3 supplementation for 16 weeks improves flow mediated dilation in overweight African- American adults. Am J Hypertens 2011; 24:557-562.
39. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1, 25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-238. (Pubitemid 34787360)
40. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase. Proc Natl Acad Sci 2008; 105:15896-15901.
41. Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003; 14:274-281. (Pubitemid 36992197)
42. Gurley SB, Coffman TM. The renin-angiotensin system and diabetic nephropathy. Sem Nephrol 2007; 27:144-152. (Pubitemid 46550312)
43. Kawaguchi H, Sawa H, Yasuda H. Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. J Mol Cell Cardiol 1990; 22:839-842. (Pubitemid 20281896)
44. Wei Y, Sowers JR, Nistala R, et al. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 2006; 281:35137-35146. (Pubitemid 46036553)
45. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998; 14:241-249. (Pubitemid 28499613)
46. Tessari P, Cecchet D, Cosma A, et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 2010; 59:2152- 2159.
47. Tare M, Emmett SJ, Coleman HA, et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 2011; 589:4777-4786.
48. Talmor Y, Golan E, Benchetrit S, et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008; 294:1059-1064.
49. Wu-Wong JR, Nakane M, Ma J, Ruan X. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells. J Cell Biochem 2007; 100:1395-1405. (Pubitemid 46515574)
50. Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011; 58:186-192.
51. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006; 29:722- 724. (Pubitemid 44115386)